Lowry-Wood syndrome

Lowry-Wood syndrome is an extremely rare genetic disorder characterized by the combination of skeletal abnormalities, short stature, and intellectual disability. The condition was first described by Lowry and Wood in 1975. Key clinical features include epiphyseal dysplasia (abnormal development of the growing ends of bones), microcephaly (abnormally small head), and small stature. Affected individuals may also present with dental anomalies, sparse hair, and distinctive facial features. The skeletal system is prominently affected, with radiographic findings showing delayed bone maturation and epiphyseal irregularities that can lead to joint problems over time. The syndrome affects multiple body systems including the skeletal, neurological, and craniofacial systems. Intellectual disability ranges from mild to moderate in reported cases. Some patients have also been noted to have nystagmus or other ophthalmologic findings. Growth deficiency is typically evident from early childhood, and final adult height is significantly below average. There is currently no specific cure or targeted treatment for Lowry-Wood syndrome. Management is supportive and symptomatic, focusing on orthopedic interventions for skeletal complications, educational support for developmental delays, and regular monitoring of growth. A multidisciplinary approach involving geneticists, orthopedic specialists, neurologists, and developmental pediatricians is recommended. Due to the extreme rarity of the condition, with only a handful of cases reported in the medical literature, knowledge about the full clinical spectrum and natural history remains limited.

Common questions about Lowry-Wood syndrome